ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1254

QI Project: Inpatient Practices in Ordering Fluorescent Anti-Nuclear Antibodies (F-ANA) and ANA Subserologies in a City Hospital in an Underserved Community

Ivan Emil Ramirez de Oleo1, Beverly Johnson2,3 and Barbara Mendez-Agrusa4, 1Internal Medicine, Jacobi Medical Center, Bronx, NY, 2Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, 3Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 4Medicine, Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ACR, ANA and antibodies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Measures and Measurement of Healthcare Quality Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: It is important for internists to know how to appropriately and effectively order subspecialty labs. As part of the choosing wisely campaign in 2013, the American College of Rheumatology (ACR) issued a series of recommendations to improve clinical practice including not to test ANA subserologies without a positive F-ANA.1

Multiple studies and laboratory guidelines have evaluated this algorithmic approach which begins with the clinical suspicion of a rheumatic disease and then assessment of F-ANA and ANA sub-serologies as indicated.2–6

Methods: A retrospective review of medical records of patients admitted to our large, urban medical center in an underserved area from June 2016 through June 2017 was performed. 460 patients in whom F-ANA or ANA-ENA panel testing was performed were examined. Case records were analyzed for the number of tests requested, the sequence of the testing, and test results. Indeterminate results in the ANA-ENA panel were not taken into consideration for the analysis. Data was analyzed using Excel 2013.

Results: One hundred ninety F-ANA and 429 ENA panels were ordered. Positive results were found in 56.3% (107/190) of F-ANA and 14.6% (63/429) of the ENA panels. When both F-ANA and ENA panels were requested, F-ANA was performed before the ENA panel as recommended in the minority of patients 7.5% (12/159). The majority had the two tests done at the same time 66.6% (106/159). 25.7% (41/159) had the F-ANA sent after the ENA panels. ENA panels were requested alone the majority of the time 62.9% (270/429). Females represented 57.6% of the patients.

Conclusion: The majority of the time a F-ANA was not ordered before the subserologies as per ACR recommendations. Therefore we conclude that in our hospital population the ACR guidelines are not being followed with the potential for decreased quality of care and missed diagnosis. This may be due to the cost constraints of the hospital where finances are limited and F-ANA costs $14.81 and ANA-ENA panel costs $6.09. Additionally, in our ordering system, it is not obvious that the ANA-ENA panel does not include the F-ANA. We suggest further education of the house staff about understanding the difference between the F-ANA and ANA-ENA panel as a point to start toward quality improvement in this area. Also, we feel that these results open the question of whether other hospitals and communities with limited resources are able to follow the ACR guidelines for F-ANA and ENA ordering due to financial constraints.  Further study in this area could help further inform guidelines going forward.



Disclosure: I. E. Ramirez de Oleo, None; B. Johnson, None; B. Mendez-Agrusa, None.

To cite this abstract in AMA style:

Ramirez de Oleo IE, Johnson B, Mendez-Agrusa B. QI Project: Inpatient Practices in Ordering Fluorescent Anti-Nuclear Antibodies (F-ANA) and ANA Subserologies in a City Hospital in an Underserved Community [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/qi-project-inpatient-practices-in-ordering-fluorescent-anti-nuclear-antibodies-f-ana-and-ana-subserologies-in-a-city-hospital-in-an-underserved-community/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/qi-project-inpatient-practices-in-ordering-fluorescent-anti-nuclear-antibodies-f-ana-and-ana-subserologies-in-a-city-hospital-in-an-underserved-community/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology